189 related articles for article (PubMed ID: 1985206)
1. Binding of SL3-3 enhancer factor 1 transcriptional activators to viral and chromosomal enhancer sequences.
Thornell A; Hallberg B; Grundström T
J Virol; 1991 Jan; 65(1):42-50. PubMed ID: 1985206
[TBL] [Abstract][Full Text] [Related]
2. SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus.
Hallberg B; Schmidt J; Luz A; Pedersen FS; Grundström T
J Virol; 1991 Aug; 65(8):4177-81. PubMed ID: 1649324
[TBL] [Abstract][Full Text] [Related]
3. SEF1 binding is important for T cell specific enhancers of genes for T cell receptor-CD3 subunits.
Hallberg B; Thornell A; Holm M; Grundström T
Nucleic Acids Res; 1992 Dec; 20(24):6495-9. PubMed ID: 1480471
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional activity of core binding factor-alpha (AML1) and beta subunits on murine leukemia virus enhancer cores.
Zaiman AL; Lewis AF; Crute BE; Speck NA; Lenz J
J Virol; 1995 May; 69(5):2898-906. PubMed ID: 7707514
[TBL] [Abstract][Full Text] [Related]
5. Differential protein binding in lymphocytes to a sequence in the enhancer of the mouse retrovirus SL3-3.
Thornell A; Hallberg B; Grundström T
Mol Cell Biol; 1988 Apr; 8(4):1625-37. PubMed ID: 2837650
[TBL] [Abstract][Full Text] [Related]
6. Purification of SEF1 proteins binding to transcriptional enhancer elements active in T lymphocytes.
Thornell A; Holm M; Grundström T
J Biol Chem; 1993 Oct; 268(29):21946-54. PubMed ID: 8408051
[TBL] [Abstract][Full Text] [Related]
7. CBF, Myb, and Ets binding sites are important for activity of the core I element of the murine retrovirus SL3-3 in T lymphocytes.
Zaiman AL; Nieves A; Lenz J
J Virol; 1998 Apr; 72(4):3129-37. PubMed ID: 9525638
[TBL] [Abstract][Full Text] [Related]
8. Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site.
Ethelberg S; Hallberg B; Lovmand J; Schmidt J; Luz A; Grundström T; Pedersen FS
J Virol; 1997 Feb; 71(2):1196-206. PubMed ID: 8995642
[TBL] [Abstract][Full Text] [Related]
9. Helix-loop-helix transcriptional activators bind to a sequence in glucocorticoid response elements of retrovirus enhancers.
Corneliussen B; Thornell A; Hallberg B; Grundström T
J Virol; 1991 Nov; 65(11):6084-93. PubMed ID: 1681116
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb.
Zaiman AL; Lenz J
J Virol; 1996 Aug; 70(8):5618-29. PubMed ID: 8764076
[TBL] [Abstract][Full Text] [Related]
11. Increased induction of osteopetrosis, but unaltered lymphomagenicity, by murine leukemia virus SL3-3 after mutation of a nuclear factor 1 site in the enhancer.
Ethelberg S; Tzschaschel BD; Luz A; Diaz-Cano SJ; Pedersen FS; Schmidt J
J Virol; 1999 Dec; 73(12):10406-15. PubMed ID: 10559359
[TBL] [Abstract][Full Text] [Related]
12. Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.
Ethelberg S; Lovmand J; Schmidt J; Luz A; Pedersen FS
J Virol; 1997 Oct; 71(10):7273-80. PubMed ID: 9311802
[TBL] [Abstract][Full Text] [Related]
13. Differences in activities of murine retroviral long terminal repeats in cytotoxic T lymphocytes and T-lymphoma cells.
LoSardo JE; Cupelli LA; Short MK; Berman JW; Lenz J
J Virol; 1989 Mar; 63(3):1087-94. PubMed ID: 2644446
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the significance of two single-base-pair differences in the SL3-3 and Akv virus long terminal repeats.
Morrison HL; Dai HY; Pedersen FS; Lenz J
J Virol; 1991 Feb; 65(2):1019-22. PubMed ID: 1846181
[TBL] [Abstract][Full Text] [Related]
15. The human enhancer-binding protein Gata3 binds to several T-cell receptor regulatory elements.
Marine J; Winoto A
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7284-8. PubMed ID: 1871134
[TBL] [Abstract][Full Text] [Related]
16. Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-3.
Nieves A; Levy LS; Lenz J
J Virol; 1997 Feb; 71(2):1213-9. PubMed ID: 8995644
[TBL] [Abstract][Full Text] [Related]
17. Contributions to transcriptional activity and to viral leukemogenicity made by sequences within and downstream of the MCF13 murine leukemia virus enhancer.
Tupper JC; Chen H; Hays EF; Bristol GC; Yoshimura FK
J Virol; 1992 Dec; 66(12):7080-8. PubMed ID: 1331510
[TBL] [Abstract][Full Text] [Related]
18. Suppressor mutations within the core binding factor (CBF/AML1) binding site of a T-cell lymphomagenic retrovirus.
Martiney MJ; Levy LS; Lenz J
J Virol; 1999 Mar; 73(3):2143-52. PubMed ID: 9971797
[TBL] [Abstract][Full Text] [Related]
19. PU.1 binding to ets motifs within the equine infectious anemia virus long terminal repeat (LTR) enhancer: regulation of LTR activity and virus replication in macrophages.
Hines R; Sorensen BR; Shea MA; Maury W
J Virol; 2004 Apr; 78(7):3407-18. PubMed ID: 15016863
[TBL] [Abstract][Full Text] [Related]
20. The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions.
Lieberman PM; Hardwick JM; Sample J; Hayward GS; Hayward SD
J Virol; 1990 Mar; 64(3):1143-55. PubMed ID: 2154599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
